Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.2 SEK | +1.00% | +3.06% | +30.66% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.66% | 65.41M | |
+16.20% | 78.51B | |
+13.10% | 9B | |
+42.06% | 4.96B | |
-14.54% | 4.84B | |
+9.01% | 3.72B | |
+21.94% | 2.48B | |
-27.22% | 2.19B | |
+15.83% | 2.12B | |
-39.50% | 1.94B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Orexo Hires New Chief Medical Officer